2DG Drug Guidelines: The Defense Research And Development Organization (DRDO) Has Issued Guidelines For The Use Of Its 2DG (2-Deoxy-D-Glucose) Drug In Coronavirus Patients. It Said That The Medicine Can Be Given To COVID Patients Under The Supervision And Prescription Of Doctors.
The 2-DG Drug Has Been Developed By The Institute Of Nuclear Medicine And Allied Sciences, A Laboratory Of DRDO.
DRDO Releases 2DG Drug Guidelines
2DG: 2DG Has Been Approved For Emergency Use As An Adjuvant Therapy Of Care In The Treatment Of COVID Patients In The Hospital.
Doctors Should prescribe 2DG At The Earliest For A Maximum Duration Of 10 Days For Moderate To Severe COVID Patients.
Patients With Uncontrolled Diabetes, Severe Heart Problems, ARDS (Acute Respiratory Distress Syndrome), Severe Hepatic And Renal Impairment Have Not Yet Been Studied With 2DG, So Caution Should Be Exercised.
2DG Should Not Be Given To Pregnant And Lactating Women And Patients Under 18 Years Of Age.
The 2DG medicine can be given to Covid-19 patients under the care and prescription of doctors. Directions for usage of this drug for Covid-19 patients as per DCGI approval are attached here for reference. For all queries regarding #2DG, please write to 2DG@drreddys.com pic.twitter.com/x19ayBoToG
— DRDO (@DRDO_India) June 1, 2021
DRDO Also Said That Patients And Attendants Are Advised To Request Their Hospital To Contact Dr Reddy’s Lab For the Supply Of Medicines. On May 17, Defense Minister Rajnath Singh And Union Health Minister Dr Harsh Vardhan Released The First Batch Of Medicine.
Reports Say The Test Results Have Shown That It Helps In Faster Recovery Of Hospitalized Patients And Reduces Oxygen Dependence.
On 28 May, Dr Reddy’s Announced That It Has Fixed The Price Of The Drug At Rs 990 Per Sachet. However, The Medicine Will Be Made Available To The Central And State Government Hospitals At A Subsidized Price.